Donegal Group (DGICA) Stock Chart & Stock Price History → This 1 Biotech Stock has been shocking the markets (From Huge Alerts) (Ad) Free DGICA Stock Alerts $13.19 -0.18 (-1.35%) (As of 02:27 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Donegal Group Stock Price Performance5 Day Performance-2.66%1 Month Performance-3.86%3 Month Performance-8.97%6 Month Performance-7.89%Year-To-Date Performance-5.72%1 Year Performance-7.31% Receive DGICA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Donegal Group and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Unstoppable ProsperityCharles Payne Demystifies OptionsWhen it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. DGICA Stock Chart for Thursday, May, 9, 2024 DGICA Chart by TradingView Donegal Group Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/08/2024$13.36$13.37+0.07%$13.43$13.2048,654 shs$446.42 million05/07/2024$13.53$13.36-1.26%$13.50$13.3240,036 shs$446.09 million05/06/2024$13.55$13.53-0.15%$13.76$13.4240,055 shs$451.77 million05/03/2024$13.52$13.55+0.22%$13.62$13.4027,916 shs$452.43 million05/02/2024$13.50$13.52+0.15%$13.64$13.4247,234 shs$451.43 million05/01/2024$13.44$13.50+0.45%$13.71$13.3661,113 shs$450.77 million Get the Latest News and Ratings for DGICA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Donegal Group and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024$13.35$13.44+0.67%$13.45$13.2735,024 shs$448.76 million04/29/2024$13.45$13.35-0.74%$13.53$13.3444,353 shs$445.76 million04/26/2024$13.85$13.45-2.89%$13.76$13.4044,912 shs$449.10 million04/25/2024$14.00$13.85-1.07%$14.07$13.8248,508 shs$462.49 million04/24/2024$13.80$14.00+1.45%$14.04$13.6156,354 shs$467.46 million04/23/2024$13.83$13.80-0.22%$13.93$13.7339,171 shs$460.78 million04/22/2024$14.02$13.83-1.36%$14.10$13.8242,845 shs$461.78 million04/19/2024$13.64$14.02+2.79%$14.08$13.5561,144 shs$468.13 million04/18/2024$13.38$13.64+1.94%$13.70$13.3845,400 shs$455.44 million04/17/2024$13.46$13.38-0.59%$13.56$13.3733,271 shs$446.76 million04/16/2024$13.31$13.46+1.13%$13.47$13.2530,942 shs$449.43 million04/15/2024$13.32$13.31-0.08%$13.39$13.1941,145 shs$444.42 million04/12/2024$13.40$13.32-0.60%$13.48$13.2625,687 shs$444.76 million04/11/2024$13.53$13.40-0.96%$13.56$13.2856,040 shs$447.47 million04/10/2024$13.72$13.53-1.38%$13.58$13.2958,287 shs$451.77 million04/09/2024$13.74$13.72-0.15%$13.79$13.5033,041 shs$458.11 million04/08/2024$13.77$13.74-0.22%$13.85$13.7037,164 shs$458.78 million04/05/2024$13.98$13.77-1.50%$13.93$13.6633,990 shs$459.78 million04/04/2024$13.84$13.98+1.01%$14.28$13.8669,646 shs$466.79 million04/03/2024$13.72$13.84+0.87%$13.94$13.6357,426 shs$462.12 million04/02/2024$13.88$13.72-1.15%$13.88$13.6246,539 shs$458.11 million04/01/2024$14.14$13.88-1.84%$14.12$13.7634,940 shs$463.50 million03/29/2024$14.14$14.14$14.28$14.1060,828 shs$472.14 million03/28/2024$14.04$14.14+0.71%$14.28$14.0760,828 shs$472.14 million03/27/2024$13.72$14.04+2.33%$14.06$13.8244,034 shs$468.80 million03/26/2024$13.75$13.72-0.22%$13.92$13.6747,228 shs$458.15 million03/25/2024$13.56$13.75+1.40%$13.95$13.6440,415 shs$459.11 million03/22/2024$13.96$13.56-2.87%$13.99$13.5453,837 shs$452.77 million03/21/2024$13.93$13.96+0.22%$14.07$13.9187,829 shs$466.12 million03/20/2024$14.04$13.93-0.78%$14.07$13.6871,812 shs$465.12 million03/19/2024$13.97$14.04+0.50%$14.14$13.9399,803 shs$468.80 million03/18/2024$14.20$13.97-1.62%$14.14$13.78147,047 shs$466.46 million03/15/2024$13.22$14.20+7.41%$14.22$13.10527,891 shs$472.15 million03/14/2024$13.40$13.22-1.34%$13.40$13.1264,643 shs$439.57 millionThis 1 Biotech Stock has been shocking the markets (Ad)Save the Date: BioStem's 2024 Q1 Call Coming Up!Sign Up for the Live Broadcast here03/13/2024$13.49$13.40-0.67%$13.51$13.1269,665 shs$445.55 million03/12/2024$13.56$13.49-0.52%$13.55$13.4057,370 shs$448.49 million03/11/2024$13.71$13.56-1.09%$13.76$13.5543,078 shs$450.87 million03/08/2024$13.73$13.71-0.15%$14.00$13.6154,883 shs$455.86 million03/07/2024$13.84$13.73-0.79%$13.95$13.5566,563 shs$460.13 million03/06/2024$13.73$13.84+0.80%$13.89$13.6740,012 shs$460.18 million03/05/2024$13.87$13.73-1.01%$14.00$13.7135,084 shs$456.52 million03/04/2024$13.94$13.87-0.50%$14.02$13.8432,162 shs$461.18 million03/01/2024$14.00$13.94-0.43%$14.00$13.8143,081 shs$463.51 million02/29/2024$13.86$14.00+1.01%$14.05$13.8984,719 shs$465.50 million02/28/2024$13.97$13.86-0.79%$14.10$13.7963,928 shs$460.85 million02/27/2024$14.23$13.97-1.83%$14.21$13.8577,923 shs$464.45 million02/26/2024$13.99$14.23+1.72%$14.27$13.8639,501 shs$473.15 million02/23/2024$14.41$13.99-2.91%$14.46$13.8863,493 shs$465.17 million02/22/2024$14.46$14.41-0.35%$14.58$14.2146,943 shs$479.08 million02/21/2024$14.72$14.46-1.77%$14.69$14.4232,177 shs$480.80 million02/20/2024$14.79$14.72-0.47%$14.97$14.6633,350 shs$489.44 million02/19/2024$14.79$14.79$15.02$14.7824,500 shs$491.77 million02/16/2024$15.01$14.79-1.47%$15.02$14.7824,505 shs$491.77 million02/15/2024$14.42$15.01+4.09%$15.08$14.5273,600 shs$499.08 million02/14/2024$14.33$14.42+0.63%$14.48$14.2455,023 shs$479.47 million02/13/2024$14.83$14.33-3.37%$14.77$14.2655,210 shs$476.47 million02/12/2024$14.49$14.83+2.35%$14.96$14.4765,766 shs$493.04 million02/09/2024$14.35$14.49+0.98%$14.54$14.2638,275 shs$481.79 million02/08/2024$14.27$14.35+0.56%$14.35$14.2620,530 shs$477.14 million Related Companies: GBLI Stock Chart UVE Stock Chart UFCS Stock Chart PRA Stock Chart AMSF Stock Chart EIG Stock Chart HCI Stock Chart SAFT Stock Chart GLRE Stock Chart HIPO Stock Chart Receive DGICA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Donegal Group and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DGICA) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Donegal Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.